Nanoparticles for Neurological Disorders by Sonali Sundram

Nanoparticles for Neurological Disorders by Sonali Sundram

Nanotechnology is opening new frontiers in the diagnosis and treatment of neurological disorders by overcoming many of the limitations of conventional therapies. This new volume presents a comprehensive overview of how nanoparticle-based systems are transforming the management of diseases affecting the central nervous system through targeted drug delivery, improved bioavailability, and enhanced therapeutic precision.

Beginning with the principles of nanotechnology in neurology, the book examines applications in Alzheimer’s disease, Parkinson’s disease, brain tumors, epilepsy, spinal cord injury, stroke, psychiatric disorders, dementia, meningitis, migraines, muscular dystrophy, and autoimmune and viral encephalitis. Chapters explore innovative nanoparticle platforms that improve drug transport across the blood-brain barrier, enhance neuroprotection, promote tissue regeneration, and support more effective diagnosis and treatment. The volume also discusses emerging biomaterials, nanoscaffolds, and advanced therapeutic strategies that are shaping the future of neurological care.

“Relevant and significant addition to this rapidly expanding field. . . Offers an in-depth discussion of the various applications of nanoparticle technology for treating a variety of neurological conditions. . . . Gives readers a realistic and forward-thinking viewpoint on the subject. . . . An exhaustive book that combines academic insights with practical applications. . . A valuable resource for doctors, researchers, and students alike, laying the groundwork for future advances in neurological treatment.”

—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

Sonali Sundram, PhD, is Assistant Professor at Galgotias University, India. Her research focuses on neurodegeneration, nanoformulations, clinical research, and artificial intelligence. She has authored and edited numerous scientific books and publications, holds multiple national and international patents, and actively contributes to pharmaceutical research and education.

Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with more than 15 years of research experience in nanoformulations, targeted drug delivery, and pharmaceutical excipients. He has published extensively, holds numerous patents, and has authored or edited more than 100 scientific books.

Shivam Rajput, MPharm, is a Research Scholar at Galgotias University, India. His research interests include nanoformulations, targeted drug delivery, cancer nanomedicine, and green nanotechnology. He has authored and edited numerous books and book chapters and has published research with leading international publishers.

Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and Health Sciences University, United Arab Emirates. His expertise includes clinical pharmacy, medication safety, pharmacovigilance, and pharmacoepidemiology. He has published extensively, presented internationally, and received numerous awards for teaching and research.